RemeGen Co. Ltd.SSE: 688331

(688331)"REMEGEN CO., LTD."Report for Q3 2026

Oct 30, 2026 · Issued by RemeGen Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688331 · Oct 30, 2026

On 6ix: 6ix.com/news/688331remegen-co-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)RemeGen Co. Ltd. on 6ix

Earlier from RemeGen

(688331)"REMEGEN CO., LTD."Announcement on Proposal by the Actual Controller and Chairman for the Company to Repurchase SharesOct 29
(688331)"REMEGEN CO., LTD."Announcement on the Company's Recent Production and OperationOct 24
(688331)"REMEGEN CO., LTD."Announcement on Progress of Initial Repurchase of Shares through Call Auction in 2026Oct 9
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 8
Announcement on Adjustment of Members of Special Committees of the Board of DirectorsAug 25

Later from RemeGen

(688331)"REMEGEN CO., LTD."Announcement on Resolutions of the 6th Meeting of the 3rd Board of DirectorsNov 3
(688331)"REMEGEN CO., LTD."Proposal on the Second Share Repurchase through Call Auction in 2026Nov 3

All RemeGen news releases

Follow RemeGen into a list and get an email when it puts out news.

Follow RemeGen